Genetic polymorphism of human cytochrome P450 2E1

Methods in Enzymology

Volumn 272, Issue , 1996, Pages 218-225

  Nedelcheva, Vessela ^a   Persson, Irene ^a   Ingelman Sundberg, Magnus ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; RESTRICTION ENDONUCLEASE;

ALLELE; ARTICLE; ENZYME SPECIFICITY; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; INTRON; NUCLEIC ACID BASE SUBSTITUTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION MAPPING;

EID: 0029738439     PISSN: 00766879     EISSN: None     Source Type: Book Series    
DOI: 10.1016/s0076-6879(96)72026-8     Document Type: Article

References (23)

1. M. J. J. Ronis, K. O. Lindros, and M. Ingelman-Sundberg, in "Cytochromes P450: Pharmacological and Toxicological Aspects" (I. Ioannides, ed.). CRC Press, Boca Raton, FL, 1996 (in press).
2. Y. Terelius, K. O. Lindros, K. O. E. Albano, and M. Ingelman-Sundberg, in "Frontiers of Biotransformation" (H. Rein and K. Ruckpaul, eds.), Vol. 8, p. 187. Akademie-Verlag, Berlin, 1992.
3. G. Ekström and M. Ingelman-Sundberg, Biochem. Pharmacol. 38, 1313 (1989).
4. M. Ingelman-Sundberg, I. Johansson, H. Yin, Y. Terelius, E. Eliasson, P. Clot, and E. Albano, Alcohol 10, 447 (1993).
5. E. Albano, P. Clot, M. Morimoto, A. Tomasi, M. Ingelman-Sundberg, and S. French, Hepatology 21, 1910 (1995).
6. P. Clot, M. Ingelman-Sundberg, G. Bellomo, M. Tabone, S. Aricò, Y. Israel, C. Moncada, and E. Albano, Hepatology 20, 317 (1994).
7. O. W. McBride, M. Umeno, H. V. Gelboin, and F. J. Gonzalez, Nucleic Acids Res. 15, 10071 (1987).
8. F. Uematsu, H. Kikuchi, T. Ohmachi, I. Sagami, M. Motomiya, T. Kamataki M. Komori, and M. Watanabe, Nucleic Acids Res. 19, 2803 (1991).
9. D. P. Kelsell, C. R. Wolf, and N. K. Spurr, Nucleic Acids Res. 18, 3111 (1990).
10. F. Uematsu, H. Kikuchi, T. Abe, M. Motomiya, T. Ohmachi, I. Sagami, and M. Watanabe, Nucleic Acids Res. 19, 5797 (1991).
11. S.-I. Hayashi, J. Watanabe, and K. Kawajiri, J. Biochem. (Tokyo) 110, 559 (1991).
12. J. Watanabe, S.-I. Hayashi, K. Nakachi, K. Imai, Y. Suda, T. Sekine, and K. Kawajiri, Nucleic Acids Res. 18, 7194 (1990).
13. I. Persson, I. Johansson, H. Bergling, M.-L. Dahl, J. Seidegård, R. Rylander, A. Rannug, J. Högberg, and M. Ingelman-Sundberg, FEBS Lett. 319, 207 (1993).
14. F. Uematsu, H. Kikuchi, M. Motomiya, T. Abe, I. Sagami, T. Ohmachi, A. Wakui, R. Kanamaru, and M. Watanabe, Jpn. J. Cancer Res. 82, 254 (1991).
15. A. Hirvonen, K. Husgafvel-Pursiainen, S. Anttila, A. Karjalainen, and H. Vainio, Carcinogenesis (London) 14, 85 (1993).
16. J. Watanabe, J.-P. Yang, H. Eguchi, S. Hayashi, K. Imai, K. Nakachi, and K. Kawajiri, Jpn. J. Cancer Res. 86, 245 (1995).
17. G. S. Hamada, H. Sigimura, I. Suzuki, K. Nagura, E. Kiyokawa, T. Iwase, M. Tanaka, T. Takahashi, S. Watanabe, and I. Kino, Cancer Epidemiol. Biomarkers Prev. 4, 63 (1995).
18. M. Tsutsumi, S. Takase, and A. Takada, Alcohol Alcohol., Suppl. 1B, 2 (1994).
19. Y. Maezawa, M. Yamauchi, and G. Toda, Am. J. Gastroenterol. 89, 561 (1994).
20. D. Lucas, C. Menez, C. Girre, F. Berthou, P. Bodenez, I. Joannet, E. Hispard, L.-G. Bardou, and J.-F. Menez, Pharmacogenetics 5, 298 (1995).
21. S. Kato, P. G. Shields, N. E. Caporaso, H. Sugimura, G. E. Trivers, M. A. Tucker, B. F. Trump, A. Weston, and C. C. Harris, Cancer Epidemiol. Biomarkers Prev. 63, 45 (1995).
22. F. Uematsu, S. Ikawa, H. Kikuchi, I. Sagami, R. Kanamaru, T. Abe, K. Satoh, M. Motomiya, and M. Watanabe, Pharmacogenetics 4, 58 (1994).
23. S. A. Miller, D. D. Dykes, and H. F. Polesky, Nucleic Acids Res. 16, 215 (1988).